Professor Jieun Shin, Collaborative Research with Australia and UNSW

The Infertility Center at Jamsil CHA Hospital announced on September 8 that an international collaborative study, in which Professor Jieun Shin participated, confirmed the effectiveness of a new ovarian stimulation protocol that can reduce the number of injections during the in vitro fertilization (IVF) process for women with diminished ovarian response.


Jieun Shin, Professor at Jamshil CHA Hospital Infertility Center. Jamshil CHA Hospital

Jieun Shin, Professor at Jamshil CHA Hospital Infertility Center. Jamshil CHA Hospital

View original image

The study, involving researchers from City Fertility in Australia and the University of New South Wales (UNSW), was published in the international academic journal 'Journal of Assisted Reproduction and Genetics.'


The research team conducted a randomized controlled trial with 20 patients aged 31 to 41 who had diminished ovarian response. The patients were divided into two groups: one received the 'CFA flare protocol,' which combines corifollitropin alfa (CFA), a long-acting follicle-stimulating hormone, with an intranasal gonadotropin-releasing hormone (GnRH) agonist; the other received the conventional GnRH antagonist protocol.


The average number of injections in the CFA flare protocol group was four, which was statistically significantly lower than the 11 injections administered in the conventional antagonist protocol group. The research team explained that the CFA flare protocol has the potential to reduce injection burden while maintaining adequate ovarian stimulation. Notably, the CFA flare protocol can decrease the number of follicle-stimulating hormone (FSH) injections and omit the use of GnRH antagonist injections, thereby potentially enhancing the convenience of infertility treatment.



Professor Shin stated, "Through international training, I was able to broaden my perspective on infertility treatment by encountering a variety of patient cases and the latest research trends," and added, "Based on my clinical experience and research capabilities, I will provide personalized treatments for each patient."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing